Literature DB >> 25664064

HPLC determination and clinical significance of serum prednisone in patients with nephrotic syndrome.

Chun-Mei Chen1, Yun-Cheng Xia2, Xu-Guang Zhang3, Can-Hui Peng4, Fu-You Liu2, You-Ming Peng2, Lin Sun2.   

Abstract

AIM: A rapid protocol is necessary to determine the serum concentrations of prednisone.
METHODS: The HP1100 high-performance liquid chromatographic (HPLC) system was employed. The HP Lichrosphere C8 column (250 mm × 4 mm, i.d., 5 μm particle size) was used. The mobile phase was methanol, tetrahydrofuran and water in the ratio 25:25:50. The flow rate was 1.0 ml/min. The sample was monitored by UV absorbance at 240 nm. Acetanilide was used as the internal standard, and methanol was added into the serum for depositing the protein.
RESULTS: The chromatography was effective and was not interfered with by the serum components. Good linearity was observed, within the range of 10-500 μg/L for prednisone, and the detection limit was 5 μg/L. The serum concentrations of prednisone between the nephrotic syndrome (NS) group and the control group were significantly different (P < 0.05), while there was no significant difference between the females and males of the NS group (P > 0.05). The serum ncentration of prednisone in the steroid-resistant group was lower than that in the steroid-sensitive group (P < 0.05).
CONCLUSIONS: HPLC is a practical and reliable method to determine the serum concentration of prednisone with high accuracy, precision, linearity and repeatability.

Entities:  

Keywords:  Drug monitoring; HPLC; prednisone

Year:  2014        PMID: 25664064      PMCID: PMC4307511     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Rapid liquid-chromatographic method for simultaneous determination of plasma prednisone, prednisolone, and cortisol in pediatric renal-transplant recipients.

Authors:  J H McBride; D O Rodgerson; S S Park; A F Reyes
Journal:  Clin Chem       Date:  1991-05       Impact factor: 8.327

Review 2.  Metabolism and pharmacokinetics of oxazaphosphorines.

Authors:  A V Boddy; S M Yule
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

3.  Improved liquid-chromatographic method for determination of serum cortisol.

Authors:  P M Kabra; L L Tsai; L J Marton
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

4.  Improved sample extraction before liquid chromatography of prednisone and prednisolone in human serum.

Authors:  J T Stewart; I L Honigberg; B M Turner; D A Davenport
Journal:  Clin Chem       Date:  1982-11       Impact factor: 8.327

5.  Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

Authors:  F J Frey; B M Frey; L Z Benet
Journal:  Clin Chem       Date:  1979-11       Impact factor: 8.327

6.  Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.

Authors:  F J Bruns; S Adler; D S Fraley; D P Segel
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

7.  Corticosteroid- and furosemide-induced increase in proteinuria in nephrosis.

Authors:  T Inoue; M Okamura; N Negoro; M Fujisawa; H Inariba; T Takeda; Y Kanayama
Journal:  Nephron       Date:  1990       Impact factor: 2.847

8.  Simultaneous liquid-chromatographic determination of prednisone and prednisolone in plasma.

Authors:  M H Cheng; W Y Huang; A I Lipsey
Journal:  Clin Chem       Date:  1988-09       Impact factor: 8.327

9.  Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.

Authors:  K Jindal; M West; R Bear; M Goldstein
Journal:  Am J Kidney Dis       Date:  1992-01       Impact factor: 8.860

10.  Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

Authors:  R Elhence; S Gulati; V Kher; A Gupta; R K Sharma
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.